ApprovalTrail

Company · Montreal, Quebec, Canada

Meliapharm Inc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
74
0 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
35

Drug products

Authorized products first.

NameDINStatus
AMLODIPINE02343193Cancelled Post Market
AMLODIPINE02343207Cancelled Post Market
AMLODIPINE02343215Cancelled Post Market
ATENOLOL02351331Cancelled Post Market
ATENOLOL02351358Cancelled Post Market
ATENOLOL02351366Cancelled Post Market
CARVEDILOL02344637Cancelled Post Market
CARVEDILOL02344645Cancelled Post Market
CARVEDILOL02344653Cancelled Post Market
CITALOPRAM02301822Cancelled Post Market
CITALOPRAM02301830Cancelled Post Market
CITALOPRAM02301849Cancelled Post Market
CLONAZEPAM02344602Cancelled Post Market
CLONAZEPAM02344610Cancelled Post Market
CLONAZEPAM-R02344629Cancelled Post Market
DESMOPRESSIN02346788Cancelled Post Market
DESMOPRESSIN02346796Cancelled Post Market
FINASTERIDE02348888Cancelled Post Market
FLUOXETINE02344149Cancelled Post Market
FLUOXETINE02344157Cancelled Post Market
LETROZOLE02348896Cancelled Post Market
LISINOPRIL02294583Cancelled Post Market
LISINOPRIL02294591Cancelled Post Market
LISINOPRIL02294605Cancelled Post Market
MEMANTINE02349116Cancelled Post Market
METFORMIN02242794Cancelled Post Market
METFORMIN02246965Cancelled Post Market
METOPROLOL-L02253496Cancelled Post Market
METOPROLOL-L02253518Cancelled Post Market
METOPROLOL-L02253526Cancelled Post Market
MIRTAZAPINE02252279Cancelled Post Market
MIRTAZAPINE02281732Cancelled Post Market
OLANZAPINE02348101Cancelled Post Market
OLANZAPINE02348128Cancelled Post Market
OLANZAPINE02348136Cancelled Post Market
OLANZAPINE02348144Cancelled Post Market
OLANZAPINE02348152Cancelled Post Market
OLANZAPINE ODT02348160Cancelled Post Market
OLANZAPINE ODT02348179Cancelled Post Market
OLANZAPINE ODT02348187Cancelled Post Market
ONDANSETRON02346095Cancelled Post Market
ONDANSETRON02346168Cancelled Post Market
PANTOPRAZOLE02309858Cancelled Post Market
PANTOPRAZOLE02309866Cancelled Post Market
PAROXETINE02248450Cancelled Post Market
PAROXETINE02248451Cancelled Post Market
PAROXETINE02248452Cancelled Post Market
PIOGLITAZONE02345366Cancelled Post Market
PIOGLITAZONE02345374Cancelled Post Market
PIOGLITAZONE02345382Cancelled Post Market
PRAVASTATIN02249766Cancelled Post Market
PRAVASTATIN02249774Cancelled Post Market
PRAVASTATIN02249782Cancelled Post Market
RABEPRAZOLE EC02320614Cancelled Post Market
RABEPRAZOLE EC02320622Cancelled Post Market
RISPERIDONE02303485Cancelled Post Market
RISPERIDONE02303493Cancelled Post Market
RISPERIDONE02303507Cancelled Post Market
RISPERIDONE02303515Cancelled Post Market
RISPERIDONE02303523Cancelled Post Market
RISPERIDONE02303531Cancelled Post Market
SERTRALINE02303779Cancelled Post Market
SERTRALINE02303809Cancelled Post Market
SERTRALINE02303817Cancelled Post Market
SIMVASTATIN02343142Cancelled Post Market
SIMVASTATIN02343150Cancelled Post Market
SIMVASTATIN02343169Cancelled Post Market
SIMVASTATIN02343177Cancelled Post Market
SIMVASTATIN02343185Cancelled Post Market
TOPIRAMATE02345412Cancelled Post Market
TOPIRAMATE02345439Cancelled Post Market
TOPIRAMATE02345447Cancelled Post Market
ZOPICLONE02321521Cancelled Post Market
ZOPICLONE02321548Cancelled Post Market

Notices of Compliance

Newest first.

  • PANTOPRAZOLEJanuary 20, 2014 · NOC 15142 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MEMANTINEDecember 21, 2011 · NOC 12897 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • CITALOPRAMAugust 8, 2011 · NOC 12559 · Abbreviated New Drug Submission (ANDS)
  • PAROXETINEJune 14, 2011 · NOC 12428 · New Drug Submission (NDS)
  • PAROXETINEJune 14, 2011 · NOC 12429 · Abbreviated New Drug Submission (ANDS)
  • OLANZAPINE; OLANZAPINE ODTApril 27, 2011 · NOC 12294 · Abbreviated New Drug Submission (ANDS)
  • GABAPENTINFebruary 7, 2011 · NOC 12046 · Abbreviated New Drug Submission (ANDS)
  • PRAVASTATINJanuary 14, 2011 · NOC 12001 · Abbreviated New Drug Submission (ANDS)
  • PANTOPRAZOLEDecember 29, 2010 · NOC 11964 · Abbreviated New Drug Submission (ANDS)
  • DESMOPRESSINOctober 13, 2010 · NOC 11806 · Abbreviated New Drug Submission (ANDS)
  • SERTRALINEOctober 7, 2010 · NOC 11790 · Abbreviated New Drug Submission (ANDS)
  • MEMANTINEOctober 5, 2010 · NOC 11785 · Abbreviated New Drug Submission (ANDS)
  • RISEDRONATESeptember 23, 2010 · NOC 11732 · Abbreviated New Drug Submission (ANDS)
  • RABEPRAZOLE ECMay 27, 2010 · NOC 11427 · Abbreviated New Drug Submission (ANDS)
  • ONDANSETRONMay 27, 2010 · NOC 11431 · Abbreviated New Drug Submission (ANDS)
  • PIOGLITAZONEMay 27, 2010 · NOC 11432 · Abbreviated New Drug Submission (ANDS)
  • ALENDRONATE-FCMay 27, 2010 · NOC 11435 · Abbreviated New Drug Submission (ANDS)
  • AMLODIPINEMay 27, 2010 · NOC 11440 · Abbreviated New Drug Submission (ANDS)
  • ATENOLOLMay 19, 2010 · NOC 11391 · New Drug Submission (NDS)
  • LETROZOLEApril 28, 2010 · NOC 11305 · Abbreviated New Drug Submission (ANDS)
  • FINASTERIDEApril 20, 2010 · NOC 11263 · Abbreviated New Drug Submission (ANDS)
  • METFORMINMarch 19, 2010 · NOC 11161 · New Drug Submission (NDS)
  • TOPIRAMATEMarch 16, 2010 · NOC 11136 · Abbreviated New Drug Submission (ANDS)
  • LISINOPRILMarch 16, 2010 · NOC 11138 · Abbreviated New Drug Submission (ANDS)
  • METFORMINMarch 16, 2010 · NOC 11144 · New Drug Submission (NDS)
  • QUETIAPINEMarch 16, 2010 · NOC 11145 · Abbreviated New Drug Submission (ANDS)
  • ZOPICLONEMarch 16, 2010 · NOC 11146 · Abbreviated New Drug Submission (ANDS)
  • RISPERIDONEMarch 16, 2010 · NOC 11147 · Abbreviated New Drug Submission (ANDS)
  • METOPROLOL-LMarch 16, 2010 · NOC 11148 · New Drug Submission (NDS)
  • CLONAZEPAM-RFebruary 19, 2010 · NOC 11069 · New Drug Submission (NDS)
  • CLONAZEPAMFebruary 19, 2010 · NOC 11070 · New Drug Submission (NDS)
  • CARVEDILOLFebruary 19, 2010 · NOC 11071 · Abbreviated New Drug Submission (ANDS)
  • FLUOXETINEFebruary 18, 2010 · NOC 11065 · Abbreviated New Drug Submission (ANDS)
  • MIRTAZAPINEFebruary 18, 2010 · NOC 11067 · Abbreviated New Drug Submission (ANDS)
  • SIMVASTATINFebruary 5, 2010 · NOC 11016 · Abbreviated New Drug Submission (ANDS)